Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis.
作者信息
Pardanani A, Gotlib J, Roberts A W, Wadleigh M, Sirhan S, Kawashima J, Maltzman J A, Shao L, Gupta V, Tefferi A
机构信息
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Stanford Cancer Institute, Stanford, CA, USA.
出版信息
Leukemia. 2018 Apr;32(4):1035-1038. doi: 10.1038/leu.2017.330. Epub 2017 Nov 16.
PMID:29263442
Abstract
摘要
Zotero 插件